Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 6, 2000

View Archived Issues

Increased bone formation associated with Fra-1 and deltaFosB overexpression in transgenic mice

Antileukemia immune response identified

Arimidex does not compromise subsequent treatment of breast cancer with tamoxifen

Vion and Memorial Sloan-Kettering present preclinical TAPET data

Dura acquires distribution rights for Glaxo Wellcome dermatology product line

BioSante's CAP vaccine adjuvant completes phase I clinical trial

Gene therapy trial for blocked coronary arteries commenced by Genzyme Surgical Products

NeoRx's skeletal targeted radiotherapy progresses to phase III

Phase III trial of Actimmune begins for treatment of idiopathic pulmonary fibrosis

Intranasal apomorphine phase I results reported

DTI-015 phase I/II clinical trials begin enrollment for treatment of glioblastoma multiforme

Promising phase I data reported for Enzo Biochem gene medicine

Lasofoxifene's bone protective effects tested in multiple studies

Bone strength, density improved by LY-353381 in ovariectomized rats

MCC-565 prevents bone loss due to estrogen deficiency in monkeys

Oral alphavbeta3 antagonist L-806978 inhibits bone loss in vivo

Novel tricyclic compounds from Dr. Reddy useful for hyperglycemia, hyperlipidemia, etc.

Kinase inhibitors and their use in the treatment of cancer, psoriasis and osteoporosis

R&D at Darwin Discovery leads to new group of PDE4/TNF inhibitors

Series of microtubule-stabilizing epothilone derivatives jointly developed by BMS and GBF

BioChem Pharma reveals novel compounds for hepatitis C virus

Dihydroquinazoline antitumor agents with folate-independent mechanism described by CRC

Potent topoisomerase inhibitors related to camptothecin described in recent patent

IC-351 effective and safe as once-daily or on-demand therapy for ED

HEP-187, a new vitamin D analogue with a promising profile for metabolic bone diseases

Zeldox reaches market first in Sweden

ASBMR news: potent new cathepsin K inhibitor from SB prevents bone loss in ovariectomized rats

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...